Our results identify NK cells as a key player in SIRT2-mediated tumor progression, suggesting that tumors generated in Sirt2-KI mice develop more aggressively due to a deficiency of NK cells infiltrating in TME. The gene discussed is SIRT2; the disease is neoplasm.